To determine whether SB-699551 affects BTIC survival by interfering with signaling downstream of 5-HT5A, we sought to identify the signaling pathways that might be affected in breast tumor cell lines after treatment with the compound. This evidence concerns the gene HTR5A and breast neoplasm.